PennyStockChaser.com Announces Investment Opinion on CVRG, CYTR, SVNT, ALVR and AGEN NOTE TO EDITORS: The following is an investment opinion issued by PennyStockChaser.com (PSC) Business Wire NEWARK, Del. -- June 17, 2009 PennyStockChaser.com is a leading stock website that provides free daily alerts on stocks that are moving up. Our team sifts through thousands of stocks to identify those that are poised and ready to move up. We are dedicated to providing you the right information at the right time. We want to provide investors with some general guidance in penny stocks trading. To receive more hot stock alerts, investors simply need to join our FREE newsletter service by clicking on the following link: http://www.pennystockchaser.com/join-now/ Hot stock that exploded: Converge Global Inc. (Pinksheets:CVRG) rose another 24% today. This was on top of the gain of 20% yesterday. The last time we had two big green days like this the stock jumped 2000% when it ran from $0 .022 to $0 .445. PennyStockChaser has been watching the following stocks: CytRx Corp. (NASDAQ:CYTR), Savient Pharmaceuticals Inc. (NASDAQ:SVNT), Alvarion Ltd. (NASDAQ:ALVR) and Antigenics Inc. (NASDAQ:AGEN) About PennyStockChaser.com PennyStockChaser.com is an independent electronic publication that provides information on selected publicly traded companies. PennyStockChaser.comis not a registered investment advisor or broker-dealer. PennyStockChaser.com’s affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above. Michael Scott Jacobs, CFA, of PennyStockChaser.com is a member of the National Association of Securities Dealers, CRD number 1818665. Contact: PennyStockChaser.com Mike Schonberg, 1-866-469-8524 email@example.com http://www.pennystockchaser.com
PennyStockChaser.com Announces Investment Opinion on CVRG,
Press spacebar to pause and continue. Press esc to stop.